Syngen Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 04, 2020 at 07:51 pm
Share
Syngen Biotech Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 370.130 million compared to TWD 353.958 million a year ago. Operating income was TWD 91.927 million compared to TWD 75.268 million a year ago. Net income was TWD 74.616 million compared to TWD 58.874 million a year ago. Basic earnings per share was TWD 2.75 compared to TWD 2.55 a year ago. For the half year, sales was TWD 637.808 million compared to TWD 618.353 million a year ago. Operating income was TWD 142.182 million compared to TWD 116.501 million a year ago. Net income was TWD 114.798 million compared to TWD 92.536 million a year ago. Basic earnings per share was TWD 4.24 compared to TWD 4.01 a year ago. Diluted earnings per share was TWD 4.23 compared to TWD 4 a year ago.
Syngen Biotech Co Ltd is a Taiwan-based company mainly engaged in the manufacture and distribution of active pharmaceutical ingredients and health food products. The Companyâs products mainly consist of active pharmaceutical ingredients, health food raw materials, medical equipment, such as bone density analyzers, blood glucose analyzers and biochemical analyzers, as well as animal health products and others. The Company distributes its products mainly in Taiwan, Iran, South Korea and Egypt.
SYNGEN BIOTECH CO.,LTD. 
